MYOKARDIA INC's ticker is MYOK and the CUSIP is 62857M105. A total of 160 filers reported holding MYOKARDIA INC in Q3 2019. The put-call ratio across all filers is 2.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,148,000 | +32.2% | 30,432 | -6.3% | 0.00% | 0.0% |
| Q2 2020 | $3,138,000 | +149.8% | 32,481 | +21.3% | 0.00% | +100.0% |
| Q1 2020 | $1,256,000 | -40.0% | 26,778 | -6.8% | 0.00% | 0.0% |
| Q4 2019 | $2,094,000 | +71.2% | 28,726 | +22.5% | 0.00% | 0.0% |
| Q3 2019 | $1,223,000 | +14.7% | 23,453 | +10.4% | 0.00% | 0.0% |
| Q2 2019 | $1,066,000 | +49.1% | 21,253 | +54.5% | 0.00% | – |
| Q1 2019 | $715,000 | +7.5% | 13,756 | +1.0% | 0.00% | -100.0% |
| Q4 2018 | $665,000 | -20.5% | 13,615 | +6.0% | 0.00% | 0.0% |
| Q3 2018 | $837,000 | +238.9% | 12,840 | +158.8% | 0.00% | – |
| Q2 2018 | $247,000 | +38.8% | 4,961 | +36.0% | 0.00% | – |
| Q1 2018 | $178,000 | -13.6% | 3,649 | -25.3% | 0.00% | – |
| Q4 2017 | $206,000 | -13.4% | 4,882 | -12.6% | 0.00% | – |
| Q3 2017 | $238,000 | +277.8% | 5,583 | +15.9% | 0.00% | – |
| Q2 2017 | $63,000 | +21.2% | 4,816 | +20.7% | 0.00% | – |
| Q1 2017 | $52,000 | +2.0% | 3,990 | 0.0% | 0.00% | – |
| Q4 2016 | $51,000 | +54.5% | 3,990 | +92.7% | 0.00% | – |
| Q3 2016 | $33,000 | +26.9% | 2,071 | 0.0% | 0.00% | – |
| Q2 2016 | $26,000 | – | 2,071 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 511,244 | $33,333,000 | 10.93% |
| Casdin Capital, LLC | 805,000 | $52,486,000 | 6.38% |
| Foresite Capital Management III, LLC | 372,300 | $24,274,000 | 5.36% |
| Fernwood Investment Management, LLC | 153,131 | $9,984,000 | 5.28% |
| Grace Capital | 121,304 | $7,909,000 | 3.10% |
| Cormorant Asset Management, LP | 700,000 | $45,640,000 | 2.97% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 917,000 | $59,788,000 | 2.14% |
| Perceptive Advisors | 1,089,169 | $71,014,000 | 1.90% |
| PFM Health Sciences, LP | 1,878,909 | $122,505,000 | 1.80% |
| Hillhouse Capital Management | 858,340 | $55,964,000 | 1.50% |